Tobias Freilinger
Overview
Explore the profile of Tobias Freilinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
2539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia R, Linde K, Freilinger T, Vickers A, Vertosick E, Vase L, et al.
Cochrane Database Syst Rev
. 2025 Feb;
2:CD015528.
PMID: 39932102
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To investigate whether acupuncture is more effective than 'sham' (placebo) acupuncture, no preventative treatment or routine...
2.
Ruscheweyh R, Forderreuther S, Freilinger T, Gaul C, Gossrau G, Patrick Jurgens T, et al.
Cephalalgia
. 2024 Jul;
44(7):3331024241261077.
PMID: 39033424
Background: The Migraine Disability Assessment (MIDAS) is widely used. However, there are limited data on how much a reduction in the MIDAS score indicates a change that matters to the...
3.
Ruscheweyh R, Gossrau G, Dresler T, Freilinger T, Forderreuther S, Gaul C, et al.
J Headache Pain
. 2023 Oct;
24(1):135.
PMID: 37817093
Background: Triptans are effective for many migraine patients, but some do not experience adequate efficacy and tolerability. The European Headache Federation (EHF) has proposed that patients with lack of efficacy...
4.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Schmerz
. 2023 Jan;
37(1):17-18.
PMID: 36662297
No abstract available.
5.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Nervenarzt
. 2023 Jan;
94(4):318-319.
PMID: 36645452
No abstract available.
6.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Schmerz
. 2022 Oct;
37(1):5-16.
PMID: 36287263
Migraine is the most common neurological disorder and can be associated with a high degree of disability. In addition to non-pharmacological approaches to reduce migraine frequency, pharmacological migraine preventatives are...
7.
Gossrau G, Forderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, et al.
Nervenarzt
. 2022 Oct;
94(4):306-317.
PMID: 36287216
Migraine is the most common neurological disorder and can be associated with a high degree of disability. In addition to non-pharmacological approaches to reduce migraine frequency, pharmacological migraine preventatives are...
8.
Dimitriadis K, Meis J, Neugebauer H, Barlinn K, Neumann B, Gahn G, et al.
Crit Care
. 2022 Jul;
26(1):217.
PMID: 35842675
Background: Neurologic manifestations are increasingly reported in patients with coronavirus disease 2019 (COVID-19). Yet, data on prevalence, predictors and relevance for outcome of neurological manifestations in patients requiring intensive care...
9.
Hautakangas H, Winsvold B, Ruotsalainen S, Bjornsdottir G, Harder A, Kogelman L, et al.
Nat Genet
. 2022 Feb;
54(2):152-160.
PMID: 35115687
Migraine affects over a billion individuals worldwide but its genetic underpinning remains largely unknown. Here, we performed a genome-wide association study of 102,084 migraine cases and 771,257 controls and identified...
10.
Ruschil V, Mazurak N, Hofmann M, Loskutova E, Enck P, Freilinger T, et al.
Front Neurol
. 2021 Sep;
12:713391.
PMID: 34557148
Up to 48% of patients with medically unexplained symptoms seen in neurological practice suffer from sensory symptoms, which could be of functional nature or secondary to psychiatric disorders. These patients...